ARCpoint Inc. (TSXV:ARC)

Canada flag Canada · Delayed Price · Currency is CAD
0.0100
0.00 (0.00%)
At close: Apr 28, 2026
-90.00%
Market Cap 1.28M
Revenue (ttm) 830.50K
Net Income (ttm) -2.90M
Shares Out 128.36M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 30,000
Average Volume 53,985
Open 0.0100
Previous Close 0.0100
Day's Range 0.0100 - 0.0100
52-Week Range 0.0050 - 0.0900
Beta -2.04
RSI 45.83
Earnings Date May 1, 2026

About ARCpoint

ARCpoint Inc. provides franchise systems offering drug, alcohol, DNA, and clinical lab testing and screening services in the United States. It operates in two segments, ARCpoint Franchise and AFG Services. The company offers viral testing for viruses, such as Flu, Strep, and covid; regulatory compliance testing; ailments testing; preventive care services, including annual health, heart health, thyroid, diabetes, and hormone testing; nutritional testing comprising food allergy/sensitivity and vitamin/nutrient deficiency testing; and specialty he... [Read more]

Sector Healthcare
Founded 1998
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol ARC
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

ARCpoint Earnings Call Transcript: Q3 2024

Q3 2024 saw a major joint venture with Creso Brands, expanding reach to over 370 locations and driving a $6.3M accounting gain. Revenue declined due to deconsolidation, but net income and EBITDA improved significantly. 2025 is expected to bring further growth as platform adoption increases.

1 year ago - Transcripts